http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0863148-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d5bb9b9a6d998b72b154ceb1895a3f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec7aa9366c4867ba95ac5cd4fbbaec25 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16 |
filingDate | 1997-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c9be1c640073944203bbab38c7f4256 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbe1edf13b84d15fa659be8cb9e668fd |
publicationDate | 1998-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0863148-A1 |
titleOfInvention | Compounds derived from adenosine, use of such compound as a medicament, method for synthesizing such a compound and intermediates thereof |
abstract | The invention relates to compounds derivednfrom adenosine and analogs thereof, to the use of suchncompounds in pharmaceutical compositions as a cardiotonic,na renal protectant, a cognition enhancer and/ornan antiasthmatic, to a method and to intermediates fornsynthesizing such a compound. n The compounds according to the inventionnhave the general formula (I):n n wherein R 1 is a straight or branched alkyl,ncycloalkyl, aralkyl or aryl group or H; R 2 is a straight or branched alkyl, cycloalkyl,naralkyl, aryl group each of which is optionally substitutednby at least one C 1-4 alkyl, C 1-4 alkoxy, nitro group ornhalogen; R 3 is CH 2 R 4 or CONHR 5 ; R 4 is H, OH, OR 5 , SR 5 ; R 5 is H, an alkyl or a cycloalkyl group; or a pharmaceutically acceptable salt thereof. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020509997-A |
priorityDate | 1997-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.